Zions Bancorporation, National Association’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Zions Bancorporation, National Association's REGN Position: Q2 2026 in Review
Zions Bancorporation, National Association increased its Regeneron Pharmaceuticals (REGN) stake by 0.71% in Q2 2026, buying an estimated $681 and bringing the position to 141 shares worth $87.9K. The position accounts for 0.01% of the portfolio, ranked #445.
Zions Bancorporation, National Association first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $218K in Q4 2025. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Zions Bancorporation, National Association held 141 shares of Regeneron Pharmaceuticals worth $87.9K as of Q2 2026.
- Zions Bancorporation, National Association bought 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
- Regeneron Pharmaceuticals made up 0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #445 holding.
- Zions Bancorporation, National Association first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- Zions Bancorporation, National Association's Regeneron Pharmaceuticals position peaked at $218K in Q4 2025.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.